Search Results - "Zhao, Jinge"

Ultrasensitive electrochemiluminescence assay of tumor cells and evaluation of H2O2 on a paper-based closed-bipolar electrode by in-situ hybridization chain reaction amplification by Ge, Shenguang, Zhao, Jinge, Wang, Shaopeng, Lan, Feifei, Yan, Mei, Yu, Jinghua

“…In this manuscript, a disposable paper-based analytical device comprised of a closed bipolar electrode (BPE) was fabricated for the ultrasensitive…”
Get full text

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma by Sun, Guangxi, Chen, Junru, Liang, Jiayu, Yin, Xiaoxue, Zhang, Mengni, Yao, Jin, He, Ning, Armstrong, Cameron M., Zheng, Linmao, Zhang, Xingming, Zhu, Sha, Sun, Xiaomeng, Yang, Xiaoxia, Zhao, Wanbin, Liao, Banghua, Pan, Xiuyi, Nie, Ling, Yang, Ling, Chen, Yuntian, Zhao, Jinge, Zhang, Haoran, Dai, Jindong, Shen, Yali, Liu, Jiyan, Huang, Rui, Liu, Jiandong, Wang, Zhipeng, Ni, Yuchao, Wei, Qiang, Li, Xiang, Zhou, Qiao, Huang, Haojie, Liu, Zhenhua, Shen, Pengfei, Chen, Ni, Zeng, Hao

“…TFE3 -translocation renal cell carcinoma ( TFE3 -tRCC) is a rare and heterogeneous subtype of kidney cancer with no standard treatment for advanced disease. We…”
Get full text

MOF derived core-shell CuO/C with temperature-controlled oxygen-vacancy for real time analysis of glucose by Zhao, Chen, Tang, Xiaoying, Zhao, Jinge, Cao, Jie, Jiang, Zhenqi, Qin, Jieling

“…Introducing oxygen-vacancy into the surface of the non-enzymatic sensor is supposed to be an effective way to improve inherently low catalytic activity and…”
Get full text

The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis by Zhu, Qiyu, Chen, Junru, Liu, Haoyang, Zhao, Jinge, Xu, Chenhao, Sun, Guangxi, Zeng, Hao

“…Poly (ADP- ribose) polymerase inhibitors (PARPi) has been increasingly adopted for metastatic castration-resistance prostate cancer (mCRPC) patients with…”
Get full text

Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer by Wang, Zhipeng, Liu, Haoyang, Zhu, Qiyu, Chen, Junru, Zhao, Jinge, Zeng, Hao

“…Inflammation plays a pivotal role in the progression of prostate cancer (PCa). Several immune-inflammatory indices, including neutrophil to lymphocyte ratio…”
Get full text

Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer by Zhao, Jinge, Ning, Shu, Lou, Wei, Yang, Joy C, Armstrong, Cameron M, Lombard, Alan P, D'Abronzo, Leandro S, Evans, Christopher P, Gao, Allen C, Liu, Chengfei

“…The next-generation antiandrogen drugs, XTANDI (enzalutamide), ZYTIGA (abiraterone acetate), ERLEADA (apalutamide) and NUBEQA (darolutamide) extend survival…”
Get full text

Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma by Sun, Guangxi, Zhang, Xingming, Liang, Jiayu, Pan, Xiuyi, Zhu, Sha, Liu, Zhenhua, Armstrong, Cameron M, Chen, Jianhui, Lin, Wei, Liao, Banghua, Lin, Tianhai, Huang, Rui, Zhang, Mengni, Zheng, Linmao, Yin, Xiaoxue, Nie, Ling, Shen, Pengfei, Zhao, Jinge, Zhang, Haoran, Dai, Jindong, Shen, Yali, Li, Zhiping, Liu, Jiyan, Chen, Junru, Liu, Jiandong, Wang, Zhipeng, Zhu, Xudong, Ni, Yuchao, Qin, Dan, Yang, Ling, Chen, Yuntian, Wei, Qiang, Li, Xiang, Zhou, Qiao, Huang, Haojie, Yao, Jin, Chen, Ni, Zeng, Hao

“…Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is a rare but lethal subtype of RCC. Little is known about the genomic profile of…”
Get full text

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma by Zhang, Xingming, Yin, Xiaoxue, Zhang, Haoran, Sun, Guangxi, Yang, Yaojing, Chen, Junru, Zhu, Xudong, Zhao, Peng, Zhao, Jinge, Liu, Jiandong, Chen, Ni, Wang, Jia, Shen, Pengfei, Zeng, Hao

“…In clinical practice, the detection of biomarkers is mostly based on primary tumors for its convenience in acquisition. However, immune checkpoints may express…”
Get full text

Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma by Zhang, Xingming, Yin, Xiaoxue, Zhang, Haoran, Sun, Guangxi, Yang, Yaojing, Chen, Junru, Shu, Kunpeng, Zhao, Jinge, Zhao, Peng, Chen, Ni, Wang, Jia, Shen, Pengfei, Zeng, Hao

“…Due to the significant heterogeneity of renal cell carcinoma (RCC), immune checkpoints may express differently between primary and metastatic tumor. We aimed…”
Get full text

Exploring the clinical and diagnostic value of metagenomic next-generation sequencing for urinary tract infection: a systematic review and meta-analysis by He, Sike, Liu, Haolin, Hu, Xu, Zhao, Jinge, Liang, Jiayu, Zhang, Xingming, Chen, Junru, Zeng, Hao, Sun, Guangxi

“…A new pathogen detection tool, metagenomic next-generation sequencing (mNGS), has been widely used for infection diagnosis, but the clinical and diagnostic…”
Get full text

ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling by Liu, Chengfei, Armstrong, Cameron M., Ning, Shu, Yang, Joy C., Lou, Wei, Lombard, Alan P., Zhao, Jinge, Wu, Chun-Yi, Yu, Aiming, Evans, Christopher P., Tepper, Clifford G., Li, Pui-kai, Gao, Allen C.

“…Targeting androgen signaling with the second-generation anti-androgen drugs, such as enzalutamide (Enza), abiraterone (Abi), apalutamide (Apal), and…”
Get full text

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P) by Zhu, Sha, Zhao, Jinge, Nie, Ling, Yin, Wenlian, Zhang, Yaowen, Zhao, Fengnian, Ni, Yuchao, Zhang, Xingming, Wang, Zhipeng, Dai, Jindong, Liu, Zhenhua, Chen, Junru, Zeng, Yuhao, Wang, Zilin, Sun, Guangxi, Liang, Jiayu, Zhao, Xiaochen, Zhu, Xudong, Tao, Ronggui, Yang, Jiyu, He, Ben, Chen, Ni, Shen, Pengfei, Zeng, Hao

“…Abstract Background Intraductal carcinoma of the prostate (IDC-P) is a subtype of prostate cancer featured by poor prognosis. Previous studies suggested IDC-P…”
Get full text

Construction of Targeting-Peptide-Based Imaging Reagents and Their Application in Bioimaging by Zhang, Limin, Wang, Xin, Zhao, Jinge, Sun, Beilei, Wang, Weizhi

“…Molecular imaging was developed from basic molecular recognition. It can visualize not only the expression levels of specific molecules in a living system but…”
Get full text

Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-Analysis by Chen, Junru, Ni, Yuchao, Sun, Guangxi, Liao, Banghua, Zhang, Xingming, Zhao, Jinge, Zhu, Sha, Wang, Zhipeng, Shen, Pengfei, Zeng, Hao

“…Objective: To compare the efficacy and safety of current systemic combination therapies for patients with mHSPC and help select candidates for optimal…”
Get full text

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis by Wang, Zhipeng, Ni, Yuchao, Chen, Junru, Sun, Guangxi, Zhang, Xingming, Zhao, Jinge, Zhu, Xudong, Zhang, Haoran, Zhu, Sha, Dai, Jindong, Shen, Pengfei, Zeng, Hao

“…The optimal treatment for patients with high-risk prostate cancer (PCa) remains a debate and selection of patients to receive proper therapy is still an…”
Get full text

Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma by Zhao, Junjie, Tang, Yanfeng, Hu, Xu, Yin, Xiaoxue, Chen, Yuntian, Chen, Junru, Liu, Haoyang, Liu, Haolin, Liang, Jiayu, Zhang, Xingming, Zhao, Jinge, Zhu, Sha, Ni, Yuchao, Wang, Zhipeng, Dai, Jindong, Wang, Zilin, Zhang, Yaowen, Yao, Jin, Chen, Ni, Shen, Pengfei, Liu, Zhenhua H, Zeng, Hao, Sun, Guangxi X

“…TFE3-rearranged renal cell carcinoma (TFE3-rRCC) is a rare but highly heterogeneous renal cell carcinoma (RCC) entity, of which the clinical treatment…”
Get full text

The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma by Sun, Guangxi, Zhang, Xingming, Liu, Zhenhua, Zhu, Sha, Shen, Pengfei, Zhang, Haoran, Zhang, Mengni, Chen, Ni, Zhao, Jinge, Chen, Junru, Liu, Jiandong, Dai, Jindong, Wang, Zhipeng, Zhu, Xudong, Wang, Yufang, Zeng, Hao

“…The survival of patients diagnosed with metastatic renal cell carcinoma (RCC) is still limited and the current targeted therapies are only partially effective…”
Get full text

Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis by Chen, Junru, Zhang, Yaowen, Zhang, Xingming, Zhao, Jinge, Ni, Yuchao, Zhu, Sha, He, Ben, Dai, Jindong, Wang, Zhipeng, Wang, Zilin, Liang, Jiayu, Zhu, Xudong, Shen, Pengfei, Zeng, Hao, Sun, Guangxi

“…Lacking head-to-head trial, the optimal treatment for patients with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel failure is unclear…”
Get full text

Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma by Zhao, Junjie, Pan, Xiuyi, Wang, Zilin, Chen, Yuntian, Liu, Dingbang, Shen, Yu, Wei, Xinyuan, Xu, Chenhao, Zhang, Xingming, Hu, Xu, Chen, Junru, Zhao, Jinge, Tang, Bo, Sun, Guangxi, Shen, Pengfei, Liu, Zhenhua, Zeng, Hao, Liang, Jiayu

“…A substantial proportion of patients with metastatic clear cell renal cell carcinoma (ccRCC) cannot derive benefit from immune checkpoint inhibitor (ICI) plus…”
Get full text

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors by Zhang, Haoran, Zhang, Xingming, Zhu, Xudong, Ni, Yuchao, Dai, Jindong, Zhu, Sha, Sun, Guangxi, Wang, Zhipeng, Chen, Junru, Zhao, Jinge, Zeng, Hao, Li, Zi, Shen, Pengfei

“…Purpose: It remained unclear whether tyrosine kinase inhibitors (TKIs) related renal impairment had impact on the survival of patients with metastatic renal…”
Get full text